Legal
Once again Insys has been rocked by an indictment.
Teva said Lilly’s planned drug would infringe five patents that cover its own migraine drug, which it sought U.S. Food and Drug Administration approval for on Oct. 16.
Incyte has been at the forefront of the IDO race with its candidate epacadostat.
The case was part of a consolidated trial of four women who were awarded a total of $26.7 million in compensatory damages.
The way the university handled it violated state law, according to state officials.
The company was among dozens of firms worldwide hit in the June 27 attack.
Mark Lanier, a lead attorney for the plaintiffs in one of six cases being tried raised the tampering issue during an Oct. 16 hearing.
The lawsuit was filed on behalf of members of the American military who were injured or killed by attacks between 2005 and 2009
A San Diego bankruptcy court issued a final judgement that two former Masimo employees had misappropriated trade secrets, which they turned over to Sotera Wireless.
Incyte has levelled charges of stealing company secrets against the founders of Flexus Biosciences over the hiring of Incyte’s former CSO who had access to Incyte’s scientific research.
PRESS RELEASES